Feb 23 (Reuters) - Halozyme Therapeutics Inc :
* HALOZYME THERAPEUTICS, INC. ANNOUNCES PROPOSED OFFERING OF $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
* HALOZYME THERAPEUTICS - INTENDS TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* HALOZYME THERAPEUTICS, INC. ANNOUNCES PROPOSED OFFERING OF $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
* HALOZYME THERAPEUTICS - INTENDS TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)